beadchip humanht12_v4 microarray slides (Illumina Inc)
Illumina Inc is a verified supplier 
90
Structured Review
Illumina Inc
beadchip humanht12_v4 microarray slides
Beadchip Humanht12 V4 Microarray Slides, supplied by Illumina Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/beadchip+humanht12_v4+microarray+slides/humanht+12+v4+0+expression+beadchip/pm28967919-650-7-6
Average 90 stars, based on 1 article reviews
Beadchip Humanht12 V4 Microarray Slides, supplied by Illumina Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/beadchip+humanht12_v4+microarray+slides/humanht+12+v4+0+expression+beadchip/pm28967919-650-7-6
Average 90 stars, based on 1 article reviews
beadchip humanht12_v4 microarray slides - by Bioz Stars,
2026-09
90/100 stars
Images
Related Articles
Labeling:Article Title: Chromosome 1q21.3 amplification is a trackable biomarker and actionable target for breast cancer recurrence. Article Snippet: nature medicine advance online publication Despite advances in the treatment of breast cancer, numerous patients develop recurrence and die from metastasis years after treatment.. In spite of intensive research, the molecular driver events leading to tumor recurrence remain elusive.. Identifying the key molecular events associated with tumor recurrence will allow for the development of new diagnostic and treatment solutions, which are essential for improving patient survival. Microarray:Article Title: Chromosome 1q21.3 amplification is a trackable biomarker and actionable target for breast cancer recurrence. Article Snippet: nature medicine advance online publication Despite advances in the treatment of breast cancer, numerous patients develop recurrence and die from metastasis years after treatment.. In spite of intensive research, the molecular driver events leading to tumor recurrence remain elusive.. Identifying the key molecular events associated with tumor recurrence will allow for the development of new diagnostic and treatment solutions, which are essential for improving patient survival. |